All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Study reveals antibiotics disrupt gut microbiome by increasing pancreatic protease activity across IBD and non-IBD patients

By

Lior Lobel3,5,6 Send email to [email protected]

11h ago· 43 min readenNews

Summary

This study investigates how antibiotics disrupt the gut microbiome and trigger inflammatory bowel disease (IBD)-like proteolytic activity. Using fecal metagenomics and metaproteomics, researchers analyzed patients with pouchitis, ulcerative colitis (UC), and non-IBD controls before and during antibiotic exposure. Results show that antibiotics increase pancreatic protease activity and fecal proteolytic activity while reducing bacterial protease inhibitors across all groups, disrupting the epithelial barrier. The study highlights metaproteomics as a powerful tool for understanding host-microbiome interactions.

Source

bskyStudy reveals antibiotics disrupt gut microbiome by increasing pancreatic protease activity across IBD and non-IBD patientscell.com

Key quotes

· 3 pulled
Antibiotics (Abx) are essential in medicine but can disrupt gut microbiota, potentially contributing to inflammatory bowel diseases (IBDs).
Proteomic analysis revealed increased pancreatic protease activity and fecal proteolytic activity in all groups, except in patients without IBD before Abx.
Abx-driven disruption of epithelial barrier and highlighting metaproteomics as a powerful approach for dissecting host-microbiome interactions.
Snippet from the RSS feed
The metaproteomes of patients pre- and on-antibiotics (Abx) were analyzed. Abx exposure increases pancreatic proteases and fecal proteolytic activity while reducing bacterial protease inhibitors. These shifts occur across IBD and non-IBD patients, reveali

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.